|Post Approval Clinical and Epidemiological Studies (PACES)Publish the , in Publications, Webinars|
Phase IV studies emulate the real – life setting, however, the fact that the sponsor provides medication at no cost to the patient affects the generalizability with respect to access of care and compliance that is artificially enhanced in the Phase IV setting. [ ... read more ]
|5TH ANNUAL OUTSOURCING IN CLINICAL TRIALS CANADA 2015Publish the , in Conferences, News, Webinars|
Arena International’s established OCT global series continues to attract an esteemed selection of senior industry professionals from the pharmaceutical, medical device and biotech industry. The event will be focused on how companies from the region can implement effective outsourcing strategies. The agenda for OCT Canada has been designed with close collaboration to ensure topics are timely and relevant to the challenges faced in 2015.[ ... read more ]
|Indirect treatment comparisons and network meta-analyses for managers and directors: concept and application using a non-technical, user-friendly tool Publish the , in Conferences, Webinars|
Following the successful session on budget impact analyses (Five simple and effective ways to improve budget impact analyses and obtain drug reimbursement), JSS Medical Research Image nma with citieswill be presenting Indirect treatment comparisons and network meta-analyses for managers and directors: concept and application using a non-technical, user-friendly tool. This introductory course is meant to 1) conceptualize indirect treatment comparisons (ITCs), 2) recognize the different types and 3) understand their advantages and disadvantages. The session includes a hands-on workshop using a simple ITC tool requiring no technical experience. [ ... read more ]
|Pharmacoeconomics: Five Simple and Effective Ways to Optimize Budget Impact Analyses and Obtain Drug ReimbursementPublish the , in Webinars|
This pharmacoeconomics webinar focuses on one of the key elements of the reimbursement dossier: the budget impact analysis. Five considerations are discussed to optimize the budget impact analysis’ methodology. Applying these suggestions results in a pharmacoeconomic analysis that better reflects real-life outcomes and therefore provides more realistic sales forecasts.
|Post Approval Clinical Epidemiological Studies (PACES)Publish the , in Webinars|
Post Approval Clinical and Epidemiological Studies (PACES) that include Phase IV and Post Marketing Observational Studies (PMOS) have evolved into an integral and essential phase of the drug development life cycle with implications that have comparable weight to that of the Phase II and III registrational studies. While Phase II – III controlled clinical trials provide evidence of efficacy under ideal conditions, PACES are the only source of information that allows the assessment of real – life effectiveness.